EndoInSight
Cordova
About EndoInSight
EndoInSight was founded to help reduce the terrible toll Colorectal Cancer (CRC) takes on society by providing clinicians with a cost-effective method for reducing the pain and discomfort associated with colonoscopy-based CRC screening. While inflating the colon is necessary to enhance visibility during colonoscopy, trapped air can leave patients feeling bloated and uncomfortable for hours following their procedure. It has long been known that using CO2 to inflate the colon can dramatically reduce post-procedural pain and discomfort yet adoption of the technique has been slow due to a lack of awareness concerning the benefits of CO2 and the capital expenditure related with current CO2 insufflation systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Funding stage: Seed
- Last round: Seed (Oct 2014)
- Website: endoinsight.com
- Phone: (804) 514-2969
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/endoinsight-3544431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.